Literature DB >> 3732920

Prognostic significance of growth characteristics of xenotransplanted ovarian carcinomas into nude mice.

W Kleine.   

Abstract

Human ovarian carcinomas (n = 215) were xenotransplanted into thymus-aplastic female nu/nu mice (NMRI). Growth of transplants was defined as take-off rate, growth rapidity, and feasibility of passages. In 204 cases these growth characteristics could be correlated with survival time of the individual tumor-donor patients. It could be shown that median survival time of patients without take-off was longer than with take-off. In the same way there was a significant difference between slow- and fast-growing transplants as well as in tumors with only one animal passage and with more than three passages. A life table analysis similarly shows that a good growth of a xenotransplanted human ovarian carcinoma into nude mice is correlated with a poor prognosis of individual patients. It could be demonstrated that at least in ovarian cancer growth of xenotransplants in nude mice indicates a prognostic significance.

Entities:  

Mesh:

Year:  1986        PMID: 3732920     DOI: 10.1016/0090-8258(86)90066-1

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Carcinoembryonic antigen: function in metastasis by human colorectal carcinoma.

Authors:  J M Jessup; P Thomas
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

Review 2.  Patient-derived xenograft models: an emerging platform for translational cancer research.

Authors:  Manuel Hidalgo; Frederic Amant; Andrew V Biankin; Eva Budinská; Annette T Byrne; Carlos Caldas; Robert B Clarke; Steven de Jong; Jos Jonkers; Gunhild Mari Mælandsmo; Sergio Roman-Roman; Joan Seoane; Livio Trusolino; Alberto Villanueva
Journal:  Cancer Discov       Date:  2014-07-15       Impact factor: 39.397

Review 3.  Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.

Authors:  Anthony Letai; Patrick Bhola; Alana L Welm
Journal:  Cancer Cell       Date:  2021-12-23       Impact factor: 31.743

4.  Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.

Authors:  K B Skowron; S P Pitroda; J P Namm; O Balogun; M A Beckett; M L Zenner; O Fayanju; X Huang; C Fernandez; W Zheng; G Qiao; R Chin; S J Kron; N N Khodarev; M C Posner; G D Steinberg; R R Weichselbaum
Journal:  Sci Rep       Date:  2016-10-24       Impact factor: 4.379

5.  Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY).

Authors:  Judy C Boughey; Vera J Suman; Jia Yu; Katelyn Santo; Jason P Sinnwell; Jodi M Carter; Krishna R Kalari; Xiaojia Tang; Sarah A McLaughlin; Alvaro Moreno-Aspitia; Donald W Northfelt; Richard J Gray; Katie N Hunt; Amy Lynn Conners; James N Ingle; Ann Moyer; Richard Weinshilboum; John A Copland; Liewei Wang; Matthew P Goetz
Journal:  Clin Cancer Res       Date:  2021-06-02       Impact factor: 12.531

6.  Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods.

Authors:  Nicolette G Alkema; Tushar Tomar; Evelien W Duiker; Gert Jan Meersma; Harry Klip; Ate G J van der Zee; G Bea A Wisman; Steven de Jong
Journal:  Sci Rep       Date:  2015-10-06       Impact factor: 4.379

7.  Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma.

Authors:  Ruifen Dong; Wenan Qiang; Haiyang Guo; Xiaofei Xu; J Julie Kim; Andrew Mazar; Beihua Kong; Jian-Jun Wei
Journal:  J Hematol Oncol       Date:  2016-09-21       Impact factor: 17.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.